Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-17 Option Award |
2021-03-19 4:47 pm |
N/A 2031-03-16 |
Millendo Therapeutics Inc. | MLND | Owens Julia C. Executive Chair |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:19 pm |
N/A 2031-02-25 |
Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:18 pm |
N/A 2031-02-25 |
Millendo Therapeutics Inc. | MLND | Arcudi III Louis J President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-02-09 4:36 pm |
N/A 2023-08-21 |
Millendo Therapeutics Inc. | MLND | Minai-Azary Jennifer Lynn Chief Financial Officer |
0 | $0 | 105,340 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:07 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Nuechterlein Carole Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:07 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | HOWE JOHN P MD Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:07 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Gallagher Carol Giltner Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:06 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Hedley Mary Lynne Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:06 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Dable Habib J Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:05 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | NICHOL GEOFFREY Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:05 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Hindman James M. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-05-25 Option Award |
2020-05-27 9:45 pm |
N/A 2030-05-24 |
Millendo Therapeutics Inc. | MLND | Arcudi III Louis J Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-05-25 Option Award |
2020-05-27 9:40 pm |
N/A 2030-05-24 |
Millendo Therapeutics Inc. | MLND | Zeidan Ryan Chief Development Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-05-25 Option Award |
2020-05-27 9:39 pm |
N/A 2030-05-24 |
Millendo Therapeutics Inc. | MLND | JOSEPH TAMARA L General Counsel and Secretary |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-05-25 Option Award |
2020-05-27 9:38 pm |
N/A 2030-05-24 |
Millendo Therapeutics Inc. | MLND | Arbet-Engels Christophe Chief Medical Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-05-25 Option Award |
2020-05-27 9:34 pm |
N/A 2030-05-24 |
Millendo Therapeutics Inc. | MLND | Owens Julia C. President and CEO |
282,000 | $0 | 282,000 (Direct) |
View |